7
Total investments
1
Early stage
2
Mid stage
2
Late stage
8y
Years active
Portfolio
6 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Feb 2026
Erebor is a nationally chartered bank built for the next century of American innovation.
Investor
Nov 2024
At Rain AI, we’re creating a future with abundant and scalable artificial intelligence. Were building the world’s most cost and energy efficient hardware for AI. Our products achieve an order of magnitude improvement over the status quo by co-designing every layer of the AI stack, from circuits to algorithms.
Rain AI is currently a Series A stage startup and backed by world leaders in AI. Our seed round was led by Sam Altman (OpenAI). In addition, our current VC partners include Y Combinator, Daniel Gross, Jaan Tallinn, Founders X Fund, Airbus Ventures, Liquid 2 Ventures and Deepwater.
Investor
Apr 2023
Walter, a machine learning algorithm designed to give you the edge you need in fantasy sports
Investor
Nov 2019
Rubrik (NYSE: RBRK), the Security and AI company, operates at the intersection of data protection, cyber resilience and enterprise AI acceleration. The Rubrik Security Cloud platform is designed to deliver robust cyber resilience and recovery including identity resilience to ensure continuous business operations, all on top of secure metadata and data lake.
Follow @rubrikInc on X (formerly Twitter), YouTube, and Instagram.
Investor
Oct 2018
Compass Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. Compass’ scientific focus is on the relationship between angiogenesis, the immune system and tumor growth. The company pipeline of novel product candidates is designed to target multiple critical biological pathways required for an effective anti-tumor response. These include modulation of the microvasculature via angiogenesis-targeted agents, induction of a potent immune response via activators on effector cells in the tumor microenvironment, and alleviation of immunosuppressive mechanisms used by tumors to evade immune surveillance. Compass plans to advance its product candidates through clinical development as both standalone therapies and in combination with proprietary pipeline antibodies based on supportive clinical and nonclinical data. The company was founded in 2014 and is headquartered in Boston, Massachusetts.
To learn more, visit www.compasstherapeutics.com
Investor
Aug 2018
Its simple, we believe life is more fun when youre in on the action. For that reason, we’re committed to responsibly creating the world’s favorite games and betting experiences.
At DraftKings, The Crown Is Yours.
We are driven by the thrill of the future and the pull of possibility. As an original, continuous gamechanger, we’re shaping the present and future of sports entertainment and digital experiences, leading the way into new markets with new products, and providing the ultimate experience to our customers.
Here, we believe in the power and impact that comes from innovation, collaboration, and a winning culture. We’re a strong and dedicated global team of 4,000+ teammates driven to achieve great things. From your very first day, you’ll be part of an amazing culture that welcomes your ideas, champions your growth, and values you for you.
Ready to own what’s next?
Experience · 12 entries
All (12)
Investments (7)
Founder (2)
2026
Investor
Feb 2026
Erebor is a nationally chartered bank built for the next century of American innovation.
2024
Investor
Nov 2024
At Rain AI, we’re creating a future with abundant and scalable artificial intelligence. Were building the world’s most cost and energy efficient hardware for AI. Our products achieve an order of magnitude improvement over the status quo by co-designing every layer of the AI stack, from circuits to algorithms.
Rain AI is currently a Series A stage startup and backed by world leaders in AI. Our seed round was led by Sam Altman (OpenAI). In addition, our current VC partners include Y Combinator, Daniel Gross, Jaan Tallinn, Founders X Fund, Airbus Ventures, Liquid 2 Ventures and Deepwater.
2023
Investor
Apr 2023
Walter, a machine learning algorithm designed to give you the edge you need in fantasy sports
2020
Founder
Sep 2020
Next Round Capital is an advisory firm focused on private markets (primarily VC + Co-Investments). Our focus is on raising primary capital and facilitating secondary transactions in late stage unicorn companies. We help private company shareholders achieve liquidity by carefully vetting and matching them with leading institutions, family offices, and other active private share buyers.
Next Round Capital is known for delivering best-in-class service related to liquidity solutions and alternative investments while providing key market pricing, depth and ability to execute. Drawing upon decades of Wall Street and Silicon Valley experience, our team has successfully executed transactions exceeding $1 billion in value for venture-backed companies spanning SaaS, Fintech, Consumer, and numerous other sectors.
We assist private company shareholders attain liquidity by facilitating key connections with institutional investors, family offices, and other engaged buyers of private shares. Moreover, our accomplished track record includes raising in excess of $2 billion in capital for preeminent investment managers operating within the domains of private equity, venture capital, and real assets.
Show all 12 entries ↓
Investment activity
2018–2026 · 7 investments
Recent (last 2 years)Earlier
